Sign in
4

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0001062993-25-014993

Director sold 17,040 shares at $56.36 ($960,388)

  • Director acquired 17,040 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Nusse Roeland Director 2025-08-25 Option exercise +17,040 $21.84 $372,154 61,599 D
Nusse Roeland Director 2025-08-25 Sale −17,040 $56.36 $960,388 44,559 D
Derivatives
Nusse Roeland Director 2025-08-25 Option exercise · Stock Options (Right to Buy) −17,040 0 D
Open-market sales · 17,040 sh · avg $56.36 · $960,388
Loading xslF345X05/form4.xml…